CORC

在结果中检索

CORC

浏览/检索结果: 共9条，第1-9条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China 期刊论文
BMC GASTROENTEROLOGY, 2019, 卷号: 19
作者:  Sun, Jian;  Ding, Huiguo;  Chen, Guofeng;  Wang, Guiqiang;  Wei, Lai
收藏  |  浏览/下载：41/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
HBsAg and HBeAg in the prediction of a clinical response to peginterferon alpha-2b therapy in Chinese HBeAg-positive patients 期刊论文
VIROLOGY JOURNAL, 2016, 卷号: 13
作者:  Yang, Song;  Xing, Huichun;  Wang, Yuming;  Hou, Jinlin;  Luo, Duande
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05
Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study 期刊论文
JOURNAL OF HEPATOLOGY, 2016, 卷号: 65, 期号: 4
作者:  Sun, Jian;  Ma, Hong;  Xie, Qing;  Xie, Yao;  Sun, Yongtao
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/06
Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial 期刊论文
JOURNAL OF CLINICAL VIROLOGY, 2014, 卷号: 61, 期号: 4
作者:  Cheng, Jun;  Wang, Yuming;  Hou, Jinlin;  Luo, Duande;  Xie, Qing
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19
A Novel Estimation of the Impact of Treatment with Entecavir on Long-Term Mortality, Morbidity, and Health Care Costs of Chronic Hepatitis B in China. 期刊论文
Value in health regional issues, 2013, 卷号: 2, 期号: 1
作者:  Wei Lai;  Hu Shanlian;  Hou Jinlin;  Liu Gordon;  Ren Hong
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19
ON-TREATMENT QUANTIFICATION OF HBSAG IN DIFFICULT-TO-TREAT PATIENTS WITH LAMIVUDINE RESISTANCE CAN HELP IDENTIFY THOSE MOST LIKELY TO ACHIEVE SUSTAINED POST-TREATMENT RESPONSE TO PEGINTERFERON ALFA-2A RESCUE THERAPY 会议论文
作者:  Hou, Jinlin;  Sun, Jian;  Xie, Qing;  Li, Xiuhui;  Zhang, Jiming
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19
EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2A VERSUS ADEFOVIR DIPIVOXIL (ADV) IN TREATING LAMIVUDINE RESISTANT HBEAG POSITIVE CHB: AN INTERIM ANALYSIS OF A PROSPECTIVE RANDOMIZED STUDY 会议论文
作者:  Hou, Jinlin;  Sun, Jian;  Xie, Qing;  Li, Xiuhui;  Zhong, Jiming
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace